Apple Triumphs in High-Stakes Legal Battle Over Heart Monitoring Patents
Apple Prevails in Legal Battle with AliveCor Over Apple Watch
Apple has secured a significant victory in its ongoing patent dispute with health technology company AliveCor, which began several years ago and involved multiple legal battles. The central issue was whether Apple's heart rate monitoring features on the Apple Watch infringed upon three of AliveCor’s patents.
Key Points:
-
Initial Accusation (2021): AliveCor filed a complaint with the International Trade Commission (ITC), alleging that Apple's Apple Watch infringed on its patents for heart rate monitoring technology.
-
ITC Initial Finding (June 2022): The ITC initially found in favor of AliveCor, agreeing that Apple had infringed on its patented technology.
-
Apple's Response to PTAB (December 2022): In response, Apple requested a review by the Patent Trial and Appeal Board (PTAB), which ultimately ruled that the three AliveCor patents were unpatentable, meaning they were either too obvious or too generic.
-
ITC Ruling on Conditionality: Shortly after the PTAB's decision, the ITC issued an exclusion order against Apple, but it was put on hold pending the outcome of AliveCor’s appeal to the PTAB's ruling.
-
Federal Circuit Decision (March 2025): The US Court of Appeals for the Federal Circuit upheld the PTAB's decision, invalidating the three AliveCor patents. As a result, the ITC case against Apple was dismissed.
Apple’s Statement:
Apple expressed gratitude to the Federal Circuit for its thorough review and emphasized its commitment to developing health, wellness, and safety features that positively impact users' lives. The company stated it would continue to innovate in these areas.
